BSE Live
Oct 10, 11:26Prev. Close
5476.10
Open Price
5453.70
Bid Price (Qty.)
5466.15 (18)
Offer Price (Qty.)
5473.55 (8)
NSE Live
Oct 10, 11:26Prev. Close
5480.50
Open Price
5480.50
Bid Price (Qty.)
5469.50 (127)
Offer Price (Qty.)
5470.00 (6)
Balance Sheet of Alkem Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | |
12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | |||
SHAREHOLDER'S FUNDS | |||
Equity Share Capital | 23.91 | 11.96 | |
Total Share Capital | 23.91 | 11.96 | |
Reserves and Surplus | 2,975.14 | 2,643.14 | |
Total Reserves and Surplus | 2,975.14 | 2,643.14 | |
Total Shareholders Funds | 2,999.05 | 2,655.10 | |
Minority Interest | 85.65 | 0.00 | |
NON-CURRENT LIABILITIES | |||
Long Term Borrowings | 33.43 | 232.25 | |
Deferred Tax Liabilities [Net] | 96.35 | 60.91 | |
Other Long Term Liabilities | 5.14 | 7.79 | |
Long Term Provisions | 66.58 | 27.78 | |
Total Non-Current Liabilities | 201.50 | 328.73 | |
CURRENT LIABILITIES | |||
Short Term Borrowings | 1,128.57 | 845.22 | |
Trade Payables | 461.92 | 305.73 | |
Other Current Liabilities | 331.07 | 187.91 | |
Short Term Provisions | 84.42 | 25.01 | |
Total Current Liabilities | 2,005.98 | 1,363.87 | |
Total Capital And Liabilities | 5,295.76 | 4,347.70 | |
ASSETS | |||
NON-CURRENT ASSETS | |||
Tangible Assets | 972.65 | 877.19 | |
Intangible Assets | 59.59 | 32.39 | |
Capital Work-In-Progress | 110.69 | 70.68 | |
Fixed Assets | 1,142.93 | 980.26 | |
Non-Current Investments | 419.73 | 338.23 | |
Deferred Tax Assets [Net] | 4.48 | 5.11 | |
Long Term Loans And Advances | 542.17 | 438.48 | |
Other Non-Current Assets | 506.30 | 782.70 | |
Total Non-Current Assets | 2,957.71 | 2,735.21 | |
CURRENT ASSETS | |||
Current Investments | 61.05 | 249.73 | |
Inventories | 784.23 | 620.33 | |
Trade Receivables | 527.08 | 373.46 | |
Cash And Cash Equivalents | 790.76 | 206.29 | |
Short Term Loans And Advances | 129.63 | 129.92 | |
OtherCurrentAssets | 45.30 | 32.76 | |
Total Current Assets | 2,338.05 | 1,612.49 | |
Total Assets | 5,295.76 | 4,347.70 | |
OTHER ADDITIONAL INFORMATION | |||
CONTINGENT LIABILITIES, COMMITMENTS | |||
Contingent Liabilities | 309.71 | 193.85 | |
BONUS DETAILS | |||
Bonus Equity Share Capital | 11.96 | 5.98 | |
NON-CURRENT INVESTMENTS | |||
Non-Current Investments Quoted Market Value | 164.12 | 59.76 | |
Non-Current Investments Unquoted Book Value | 261.97 | 278.47 | |
CURRENT INVESTMENTS | |||
Current Investments Quoted Market Value | 10.22 | 253.45 | |
Current Investments Unquoted Book Value | 51.76 | 7.34 |
29.09.2025
23.09.2025
19.09.2025
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.06.2025
Alkem Lab Standalone March 2025 Net Sales at Rs 2,044.94 crore, down 13.55% Y-o-Y
05.06.2025
Alkem Lab Consolidated March 2025 Net Sales at Rs 3,143.75 crore, up 7.08% Y-o-Y
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key